Substance P but not vasoactive intestinal peptide modulates immunoglobulin secretion in murine schistosomiasis.
Neuropeptides including SP and VIP modulate Ig secretion by in vitro stimulated lymphocyte cultures. It is not known whether these neuropeptides effect the B cell directly, or if they significantly alter humoral immune responses to pathogens. We have previously shown that granulomas derived from schistosome-infected mice contain immunoglobulin secreting B cells (ISC) as well as eosinophils that secrete substance P (SP) and vasoactive intestinal peptide (VIP). It therefore seemed plausible that B cells derived from infected animals might respond to these neuropeptides, and that such responses might effect immunoregulatory signals. In this study, we addressed these issues in the murine Schistosoma mansoni model, at the level of immunoglobulin secretion in single B cells. Spontaneous ISC were observed in both splenic and granuloma cell preparations. The addition of SP resulted in a dose-dependent reduction in the number and size of plaques (a 50% reduction was observed at 10(-9) M). This effect was blocked with SP antagonists. Similar results were observed in T cell-depleted cell cultures. VIP had no effect on ISC number or plaque size. We conclude that SP, but not VIP, decreases spontaneous ISC number and Ig secretion in short-term cultures of spleen and granuloma cells. SP appears to exert its effects at the level of single B cells through a receptor-mediated mechanism and may thus play an immunoregulatory role in schistosomiasis.
Neil
G A
GA
Department of Internal Medicine, University of Iowa, Iowa City 52242.
Blum
A
A
Weinstock
J V
JV
D000818:Animals; D001402:B-Lymphocytes / Q000187:drug effects*; D015536:Down-Regulation; D005260:Female; D007136:Immunoglobulins / Q000378:metabolism*; D051379:Mice; D008808:Mice, Inbred CBA; D018040:Receptors, Neurokinin-1; D017981:Receptors, Neurotransmitter / Q000032:analysis; D012552:Schistosomiasis / Q000276:immunology*; D013154:Spleen / Q000187:drug effects / Q000276:immunology; D013373:Substance P / Q000494:pharmacology*; D014660:Vasoactive Intestinal Peptide / Q000494:pharmacology*
D007136:Immunoglobulins; D018040:Receptors, Neurokinin-1; D017981:Receptors, Neurotransmitter; D013373:Substance P; D014660:Vasoactive Intestinal Peptide